These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2898463)
1. Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-I-carrying MT-4 cells persistently infected with HIV. Ikuta K; Morita C; Nakai M; Yamamoto N; Kato S Jpn J Cancer Res; 1988 Apr; 79(4):418-23. PubMed ID: 2898463 [TBL] [Abstract][Full Text] [Related]
2. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1. Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175 [TBL] [Abstract][Full Text] [Related]
3. A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. Albert J; Bredberg U; Chiodi F; Böttiger B; Fenyö EM; Norrby E; Biberfeld G AIDS Res Hum Retroviruses; 1987; 3(1):3-10. PubMed ID: 3040053 [TBL] [Abstract][Full Text] [Related]
4. Coexistence of fusion receptors for human T-cell leukemia virus type-I (HTLV-I) and human immunodeficiency virus type-1 (HIV-1) on MOLT-4 cells. Kannagi M; Kuroda MJ; Maeda Y; Harada S Microbiol Immunol; 1991; 35(9):729-40. PubMed ID: 1687290 [TBL] [Abstract][Full Text] [Related]
5. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells. Ohki K; Kishi Y; Nishino Y; Sumiya M; Kimura T; Goto T; Nakai M; Ikuta K J Acquir Immune Defic Syndr (1988); 1991; 4(12):1233-40. PubMed ID: 1682474 [TBL] [Abstract][Full Text] [Related]
7. The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1. Goto T; Ikuta K; Zhang JJ; Morita C; Sano K; Komatsu M; Fujita H; Kato S; Nakai M Arch Virol; 1990; 111(1-2):87-101. PubMed ID: 1691624 [TBL] [Abstract][Full Text] [Related]
8. Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events. Harada S; Koyanagi Y; Yamamoto N Virology; 1985 Oct; 146(2):272-81. PubMed ID: 2413616 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the safety of blood products with respect to human immunodeficiency virus infection by using an HTLV-I-infected cell line (SKT-1B). Koito A; Shirono K; Suto H; Matsushita S; Hattori T; Takatsuki K Jpn J Cancer Res; 1987 Apr; 78(4):365-71. PubMed ID: 2884206 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells. Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467 [TBL] [Abstract][Full Text] [Related]
11. Ultrastructure and morphogenesis of human immunodeficiency virus. Nakai M; Goto T J Electron Microsc (Tokyo); 1996 Aug; 45(4):247-57. PubMed ID: 8888583 [TBL] [Abstract][Full Text] [Related]
12. Substances affecting the infection and replication of human immunodeficiency virus (HIV). Yamamoto N; Harada S; Nakashima H AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346 [TBL] [Abstract][Full Text] [Related]
13. Ultrastructure of human retroviruses. Palmer E; Goldsmith CS J Electron Microsc Tech; 1988 Jan; 8(1):3-15. PubMed ID: 2854553 [TBL] [Abstract][Full Text] [Related]
14. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487 [TBL] [Abstract][Full Text] [Related]
16. Human retroviruses: a decade of discovery and link with human disease. Gallo RC J Infect Dis; 1991 Aug; 164(2):235-43. PubMed ID: 1677372 [No Abstract] [Full Text] [Related]
17. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]. Ito M; Nakashima H; Baba M; Pauwels R; De Clercq E; Shigeta S; Yamamoto N Antiviral Res; 1987 Mar; 7(3):127-37. PubMed ID: 3475037 [TBL] [Abstract][Full Text] [Related]
18. Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line. Meissner ME; Mendonça LM; Zhang W; Mansky LM J Virol; 2017 Aug; 91(16):. PubMed ID: 28615198 [TBL] [Abstract][Full Text] [Related]
19. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024 [TBL] [Abstract][Full Text] [Related]
20. A unique human immunodeficiency virus culture secreting soluble gp160. Kalyanaraman VS; Pal R; Gallo RC; Sarngadharan MG AIDS Res Hum Retroviruses; 1988 Oct; 4(5):319-29. PubMed ID: 3264172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]